Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
gastroesophageal reflux/cefalea
Il collegamento viene salvato negli appunti
Pagina 1 a partire dal 105 risultati
Correlation of gastroesophageal reflux disease with positive family history and headache in Shiraz city, southern Iran.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To analyze the potential correlation of a positive family history of gastroesophageal reflux disease (GERD) and the history of headaches as a risk factor for and complication of the disease.
METHODS
Three thousand and six hundred subjects were selected by cluster random sampling from all
In adults (ages 20 - 50) with gastroesophageal reflux disease taking a proton pump inhibitor daily who present with new onset headache, are there common co-morbid conditions?
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To determine treatment satisfaction in patients with gastro-oesophageal reflux disease (GORD) when switched to esomeprazole.
METHODS
This observational, multicentre study conducted in the Netherlands included primary-care patients being treated with a proton pump inhibitor (PPI)
Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To assess the efficacy and safety of lansoprazole in the treatment of adolescents with symptomatic, endoscopically proven, non-erosive gastroesophageal reflux disease and erosive esophagitis.
METHODS
Adolescents between 12 and 17 years of age with esophagitis were enrolled in this
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To evaluate the pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability of lansoprazole in adolescents between 12 and 17 years of age with gastroesophageal reflux disease (GERD).
METHODS
Adolescents with symptomatic, endoscopically and/or histologically proven GERD
Gastrointestinal Headache; a Narrative Review.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
There are studies reporting primary headaches to be associated with gastrointestinal disorders, and some report resolution of headache following the treatment of the associated gastrointestinal disorder. Headache disorders are classified by The International Headache Society as primary or secondary;
Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND
Gastro-oesophageal reflux afflicts up to 7% of all infants. Histamine-2 receptor antagonists are the most commonly prescribed medications for this disorder, but few controlled studies support this practice.
OBJECTIVE
To evaluate the safety and efficacy of famotidine for infant
Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To evaluate safety, tolerability, and symptom improvement with once-daily esomeprazole in children with endoscopically proven gastroesophageal reflux disease (GERD).
METHODS
In this 8-week, multicenter, randomized, uncontrolled, double-blind study, children ages 1 to 11 years were
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To evaluate safety, tolerability, and symptom improvement with once-daily esomeprazole in children with endoscopically proven gastroesophageal reflux disease (GERD).
METHODS
In this 8-week, multicenter, randomized, uncontrolled, double-blind study, children ages 1 to 11 years were
Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To evaluate the safety of lansoprazole in children between 1 and 11 years of age.
METHODS
In a phase I/II, open-label, multicenter (11 sites) study, children with symptomatic gastroesophageal reflux disease (GERD), erosive esophagitis (> or = grade 2), and/or esophageal pH < 4 for > 4.2%
Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
The primary objective was to assess the safety of esomeprazole 20 or 40 mg once daily in adolescents with clinically diagnosed gastroesophageal reflux disease (GERD). A secondary aim was to assess changes in GERD symptoms after esomeprazole therapy.
METHODS
In this multicenter, randomized,
Lansoprazole: in the management of gastroesophageal reflux disease in children.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Lansoprazole, a proton pump inhibitor, inactivates the H(+)/K(+)-ATPase pump in parietal cells, thereby suppressing basal and stimulated gastric acid secretion and increasing intragastric pH. After 8-12 weeks' treatment with lansoprazole, all children (n = 27) with esophagitis at baseline were
Gastroesophageal reflux disease in an 8-year-old boy: a case study.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To present the diagnosis and management of gastroesophageal reflux disease found in a pediatric patient, to discuss the importance of a detailed case history, and to bring forward some of the most important clues, both verbal and nonverbal, that can lead to the diagnosis.
METHODS
An
Clinical experience with pantoprazole in gastroesophageal reflux disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND
Pantoprazole is a new proton pump inhibitor indicated for the treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD) and is available in both oral and intravenous (IV) formulations.
OBJECTIVE
This paper reviews the pharmacologic properties of pantoprazole
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Proton pump inhibitors are commonly used to treat gastro-esophageal reflux disease (GERD) and nonerosive GERD (NERD) in adolescents and adults. Despite the efficacy of available medications, many patients have persisting symptoms, indicating a need for more effective agents.
To assess the safety and
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
